Investor Presentation covering Full Year Results
Source: RNS
ECO Animal Health Group plc
(''ECO" or "the Group")
(AIM: EAH)
Investor Presentation covering Full Year Results
ECO Animal Health Group plc ("ECO" or "the Group"), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to announce that David Hallas, CEO, and Christopher Wilks, CFO, will be conducting a live presentation covering the Group's Full Year Results for the period ended 31 March 2022.
The online presentation will take place on Wednesday 7 September at 10.00am UK time. This event is open to all existing and potential shareholders and registration is free. Questions can be submitted during the presentation and will be addressed at the end of it.
To register for the event, please click here
A video recording of the presentation will be available shortly afterwards here
Contacts:
|
ECO Animal Health Group plc David Hallas (Chief Executive) Christopher Wilks (Finance Director)
|
|
|
IFC Advisory Graham Herring Zach Cohen
|
020 3934 6630
|
|
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas |
020 7496 3000 |
|
Investec (Joint Broker) Gary Clarence Brough Ransom Carlo Spingardi
Peel Hunt LLP (Joint Broker) Dr Christopher Golden James Steel |
020 7597 5970
020 7418 8900 |
|
Equity Development Hannah Crowe Matt Evans |
020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach†in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
